These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1257 related items for PubMed ID: 11564889
1. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Ashburner BP, Westerheide SD, Baldwin AS. Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889 [Abstract] [Full Text] [Related]
2. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Hu J, Colburn NH. Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876 [Abstract] [Full Text] [Related]
3. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes. Shaw J, Zhang T, Rzeszutek M, Yurkova N, Baetz D, Davie JR, Kirshenbaum LA. Circ Res; 2006 Dec 08; 99(12):1347-54. PubMed ID: 17082476 [Abstract] [Full Text] [Related]
4. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Zika E, Greer SF, Zhu XS, Ting JP. Mol Cell Biol; 2003 May 08; 23(9):3091-102. PubMed ID: 12697811 [Abstract] [Full Text] [Related]
5. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Liu Y, Smith PW, Jones DR. Mol Cell Biol; 2006 Dec 08; 26(23):8683-96. PubMed ID: 17000776 [Abstract] [Full Text] [Related]
6. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Dai Y, Rahmani M, Dent P, Grant S. Mol Cell Biol; 2005 Jul 08; 25(13):5429-44. PubMed ID: 15964800 [Abstract] [Full Text] [Related]
7. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Hoberg JE, Popko AE, Ramsey CS, Mayo MW. Mol Cell Biol; 2006 Jan 08; 26(2):457-71. PubMed ID: 16382138 [Abstract] [Full Text] [Related]
8. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. Zhang Y, Dufau ML. J Biol Chem; 2002 Sep 06; 277(36):33431-8. PubMed ID: 12091390 [Abstract] [Full Text] [Related]
9. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. Bhat KP, Pelloski CE, Zhang Y, Kim SH, deLaCruz C, Rehli M, Aldape KD. FEBS Lett; 2008 Sep 22; 582(21-22):3193-200. PubMed ID: 18708058 [Abstract] [Full Text] [Related]
10. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Sekhavat A, Sun JM, Davie JR. Biochem Cell Biol; 2007 Dec 22; 85(6):751-8. PubMed ID: 18059533 [Abstract] [Full Text] [Related]
11. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB. Yan JH, Gao ZG, Ye JP, Weng JP. Chin Med J (Engl); 2010 Jan 20; 123(2):221-6. PubMed ID: 20137375 [Abstract] [Full Text] [Related]
13. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene. Clem BF, Clark BJ. Mol Endocrinol; 2006 Jan 20; 20(1):100-13. PubMed ID: 16109738 [Abstract] [Full Text] [Related]
15. Histone deacetylases augment cytokine induction of the iNOS gene. Yu Z, Zhang W, Kone BC. J Am Soc Nephrol; 2002 Aug 20; 13(8):2009-17. PubMed ID: 12138131 [Abstract] [Full Text] [Related]
16. Involvement of HDAC1 and the PI3K/PKC signaling pathways in NF-kappaB activation by the HDAC inhibitor apicidin. Kim YK, Seo DW, Kang DW, Lee HY, Han JW, Kim SN. Biochem Biophys Res Commun; 2006 Sep 08; 347(4):1088-93. PubMed ID: 16870149 [Abstract] [Full Text] [Related]
17. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Ooi JY, Tuano NK, Rafehi H, Gao XM, Ziemann M, Du XJ, El-Osta A. Epigenetics; 2015 Sep 08; 10(5):418-30. PubMed ID: 25941940 [Abstract] [Full Text] [Related]
18. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Shetty S, Graham BA, Brown JG, Hu X, Vegh-Yarema N, Harding G, Paul JT, Gibson SB. Mol Cell Biol; 2005 Jul 08; 25(13):5404-16. PubMed ID: 15964798 [Abstract] [Full Text] [Related]
19. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T. Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822 [Abstract] [Full Text] [Related]
20. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter. Cicek M, Fukuyama R, Cicek MS, Sizemore S, Welch DR, Sizemore N, Casey G. Clin Exp Metastasis; 2009 Jul 08; 26(3):229-37. PubMed ID: 19165610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]